We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Azelaic Acid (topical)
A topical skincare acid applied to the skin for rosacea, acne, and uneven tone — unusual among 'cosmetic' actives because it has genuine drug-grade evidence. Azelaic acid is a naturally occurring dicarboxylic acid that is anti-inflammatory, antimicrobial, and a tyrosinase inhibitor. It is sold both as an over-the-counter cosmetic (around 10%) AND as a 15-20% prescription medication. The honest framing: the strongest, best-replicated evidence — including double-blind phase III trials and a Cochrane review that rated it high-quality for papulopustular rosacea — used the PRESCRIPTION strengths (15-20%), not the ~10% OTC cosmetic form. It also has solid evidence for acne and melasma. Head-to-head it is beaten for acne (by benzoyl peroxide + clindamycin) and tends to cause more local irritation (burning, stinging) than several comparators. For rosacea or persistent acne, the prescription form under a clinician is the evidence-based route.
Topical cosmetic ingredient — not a dietary supplement
Azelaic Acid is a topical cosmetic ingredient, not a supplement you take internally and not a drug. It is sold legally in skincare products to affect the appearance of skin (such as wrinkles). The evidence below comes mostly from small, often industry-funded studies of topical application, so treat the effect sizes cautiously. This page is for transparency and education, not a recommendation.
What the evidence says
Most Azelaic Acid studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 1987–2024 with a typical study size of 215 participants.
Based on 49 studies · 4 meta-analyses · 33 RCTs · 370 total participants
Confidence
High confidenceBy outcome
Genuine drug-grade evidence — double-blind vehicle-controlled phase III RCTs and a Cochrane review rating it high-quality for papulopustular rosacea, plus solid RCT support for acne and melasma — placing it well above typical cosmetic actives; held below the top because the strongest data used prescription strengths (15-20%, not the ~10% OTC cosmetic form), it is beaten head-to-head for acne and tolerability, and its melasma benefit does not exceed 4% hydroquinone.
64 rigorous studies
42 randomized trials · 9 meta-analyses · 13 systematic reviews
Our evidence rating for Azelaic Acid is accountable to this entire body of rigorous research indexed in PubMed — not a hand-picked subset.
PubMed · as of Jul 2026
2 trials ongoing or recruiting · 39 completed on ClinicalTrials.gov
18 of the completed trials have posted results
Registered trials show research momentum for Azelaic Acid, not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Aug 2026
Azelaic acid is a saturated nine-carbon dicarboxylic acid (nonanedioic acid) found naturally in grains such as wheat, rye, and barley, used topically on the skin.
It sits on the boundary between cosmetic and drug: lower-strength (~10%) azelaic acid is sold over the counter in cosmetics marketed for tone and texture, while 15% gel/foam and 20% cream are FDA-approved PRESCRIPTION medications for rosacea and acne respectively.
This entry describes the topical active honestly, and most of the rigorous evidence below used the prescription strengths.
Mechanistically, azelaic acid is anti-inflammatory (it scavenges reactive oxygen species and dampens neutrophil activity), antimicrobial against Cutibacterium acnes, normalises keratinisation, and inhibits tyrosinase with a relative selectivity for hyperactive melanocytes — which is why it spans rosacea, acne, and pigment disorders.
The evidence is genuinely strong for a topical.
For papulopustular rosacea, two double-blind, vehicle-controlled phase III RCTs (Thiboutot et al., 2003; 664 patients) showed 15% gel significantly outperformed vehicle, a head-to-head trial (Elewski et al., 2003; 251 patients) found it superior to 0.75% metronidazole gel, and a Cochrane systematic review (van Zuuren et al., 2015) rated the evidence for topical azelaic acid in rosacea HIGH-quality.
For acne, it reduces inflammatory and non-inflammatory lesions. For melasma, a classic 24-week double-blind RCT (Verallo-Rowell et al., 1989; 155 patients) found 20% azelaic acid superior to 2% hydroquinone (73% vs 19% good-to-excellent). Now the honest counterweights, which are mandatory here.
A head-to-head acne RCT (Schaller et al., 2016; 215 patients) found azelaic acid 20% significantly LESS effective than benzoyl peroxide 3% + clindamycin 1%, and it caused more application-site reactions.
A Cochrane melasma review (Rajaratnam et al., 2010) found 20% azelaic acid beat 2% hydroquinone but showed NO significant advantage over 4% hydroquinone, and judged melasma-trial quality generally poor.
Across uses, azelaic acid tends to cause more local irritation (burning, stinging, itching, dryness), especially early, than some comparators.
None of this is a cosmetic over-claim: azelaic acid is a well-evidenced topical whose documented benefits are dermatologic (rosacea, acne, pigmentation), with the caveat that the OTC ~10% cosmetic strength is not the concentration the registration trials tested.
For rosacea or persistent acne, the prescription form under a clinician is the evidence-based route. It is listed under Beauty & Appearance so it is discoverable, but is sandboxed out of ingestible-supplement stacks and the schedule optimizer; it carries a cosmetic badge and a topical-only disclaimer.
Azelaic acid scavenges reactive oxygen species and dampens neutrophil activity and inflammatory signalling. This anti-inflammatory action underlies its benefit in papulopustular rosacea and inflammatory acne, calming redness and inflammatory lesions.
It has antibacterial activity against Cutibacterium acnes and helps normalise the follicular keratinisation that contributes to comedone formation. Together these address the microbial and obstructive drivers of acne.
Azelaic acid inhibits tyrosinase and has a relative selectivity for hyperactive (abnormal) melanocytes, which is why it lightens melasma and post-inflammatory hyperpigmentation while tending to spare normally pigmented skin.
Topical azelaic acid is often considered one of the more reassuring actives in pregnancy, but evidence is limited — discuss any treatment with your clinician, especially prescription strengths.
Introduce slowly; early burning/stinging is common. Reduce frequency if irritation persists.
See a clinician — the prescription 15-20% form has the strongest evidence and may be combined with other treatments.
Combining azelaic acid with other irritating actives can stack local irritation; introduce one at a time and consider alternating. This is a tolerability/formulation consideration, not a systemic drug interaction — it is not ingested.
Tip: Usually transient and eases over the first weeks; reduce frequency if needed.
Tip: Buffer with moisturizer and start once daily before moving to twice daily.
Tip: Monitor, particularly on darker skin tones; discuss with a clinician if it occurs.
Azelaic Acid has an evidence score of 7.5/10 — strong evidence based on 46 indexed studies. A topical skincare acid applied to the skin for rosacea, acne, and uneven tone — unusual among 'cosmetic' actives because it has genuine drug-grade evidence. Azelaic acid is a naturally occurring dicarboxylic acid that is anti-inflammatory, antimicrobial, and a tyrosinase inhibitor. It is sold both as an over-the-counter cosmetic (around 10%) AND as a 15-20% prescription medication. The honest framing: the strongest, best-replicated evidence — including double-blind phase III trials and a Cochrane review that rated it high-quality for papulopustular rosacea — used the PRESCRIPTION strengths (15-20%), not the ~10% OTC cosmetic form. It also has solid evidence for acne and melasma. Head-to-head it is beaten for acne (by benzoyl peroxide + clindamycin) and tends to cause more local irritation (burning, stinging) than several comparators. For rosacea or persistent acne, the prescription form under a clinician is the evidence-based route. Representative study: PMID 25919144.
The commonly studied dose of Azelaic Acid is Topical only. OTC cosmetic azelaic acid is typically around 10%; prescription strengths are 15% gel/foam (rosacea) and 20% cream (acne), applied as a thin layer to clean skin once or twice daily. There is no oral, injectable, or systemic dose. For rosacea or persistent acne, the prescription form under a clinician is the evidence-based route. This library does not provide an ingestion protocol.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Timing is flexible for Azelaic Acid — consistent daily use matters more than the time of day. Azelaic acid is a leave-on topical applied once or twice daily (often AM and PM) to clean skin; there is no meal-timing relationship.
Azelaic Acid is generally safe at recommended doses, with a few precautions worth noting. The most commonly reported side effects are burning, stinging, or tingling, itching, dryness, or scaling at the site, temporary skin lightening at the application area. Use caution if any of these apply to you: For topical (skin) use only — not for ingestion, not for injection; Known allergy or sensitivity to azelaic acid or formulation excipients; Application to broken, severely irritated, or compromised skin until healed.
Tretinoin (Retin-A)
Mostly mechanism / observationalA prescription TOPICAL retinoid (Retin-A, Renova) — the acid form of vitamin A and the gold-standard, best-evidenced topical treatment for photoaging and acne. Multiple double-blind RCTs show it reduces fine wrinkles, mottled hyperpigmentation, and roughness over months, with histologic increases in dermal collagen. Caveats: retinoid dermatitis (irritation, peeling, dryness), photosensitivity, and it is CONTRAINDICATED IN PREGNANCY. Prescription drug, not a supplement; distinct from weaker OTC 'retinol' cosmetics.
Adapalene
Mostly mechanism / observationalA modern topical retinoid for acne — now available over the counter (0.1%) as well as by prescription (0.3%). A drug, not a supplement or cosmetic. Adapalene is a third-generation retinoid selective for the retinoic-acid receptor beta; it normalizes how skin cells shed (comedolytic) and is anti-inflammatory. The honest framing: this is one of the best-evidenced acne treatments — a 5-trial meta-analysis and a 40-trial network meta-analysis show it matches tretinoin's efficacy with faster onset and notably better tolerability, and the adapalene-benzoyl peroxide combination is among the most effective regimens available. Caveats: it still causes retinoid irritation and slow onset, it is not superior to (only as good as) other retinoids, and — as a retinoid — it is generally avoided in pregnancy.
Benzoyl Peroxide
Mostly mechanism / observationalA frontline over-the-counter acne medicine applied to the skin — a drug, not a supplement or cosmetic. Benzoyl peroxide (BPO) kills the acne bacterium Cutibacterium (Propionibacterium) acnes by an oxidative mechanism that, crucially, does NOT drive antibiotic resistance, and it is also mildly comedolytic and anti-inflammatory. The honest framing: this is one of the best-evidenced topical acne treatments — a 120-trial Cochrane review and a 35-RCT network meta-analysis show it beats placebo and matches topical antibiotics — but it commonly causes dryness and irritation, it bleaches fabrics, towels, and hair, and BPO monotherapy is consistently outperformed by fixed combinations (adapalene-BPO, clindamycin-BPO). A genuinely effective acne drug with real, manageable downsides.
Sunscreen (SPF)
Mostly mechanism / observationalDaily broad-spectrum sunscreen — the single most evidence-based anti-aging skincare step there is, and the one most 'anti-aging' actives are really just trying to compensate for. The honest framing: this is the only topical on this list backed by a proper randomized controlled trial for skin aging itself. In the landmark Hughes 2013 trial (n=903), people randomized to daily sunscreen showed 24% less photoaging over 4.5 years — and no detectable increase in skin aging at all — while the mechanism (UV → matrix-metalloproteinase activation → collagen breakdown) is textbook. The same trial cohort also had less skin cancer. The honest caveats: the benefit is overwhelmingly prevention, not reversal of existing damage; real-world results depend entirely on applying enough and reapplying; and chemical (organic) UV filters are systemically absorbed above an FDA testing threshold (clinical significance unknown — mineral zinc-oxide/titanium-dioxide filters sidestep this). If you do one thing for your skin, it's this.
Skincare Layering Guide
AM/PM order, what to combine vs separate, and why sunscreen always comes first.
Anti-Aging: What Works vs What's Hype
The proven core (sunscreen, retinoids, vitamin C) vs the viral hype tier — honestly tiered.
Melasma & Dark Spots
The depigmenter playbook (hydroquinone, azelaic, tranexamic, vitamin C) with sunscreen as the spine.
Acne: What Actually Works
Benzoyl peroxide & retinoids → salicylic/azelaic/niacinamide → naturals, tiered by evidence.
Explore: Best supplements for Skin, Hair & Beauty
Reviewed by Dr. Baher Al Hakim · Last reviewed June 2026 · evidence from 49 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.